Adverse Event Reporting in Clinical Trials Analysis of adverse events attribution and reporting in cancer clinical trials: A systematic review ScienceDirect In 2023, the FDA banned 19 peptides from compounding pharmacies. No specific safety incident. No clear signal. Just a regulatory decision that pushed millions of patients toward gray market suppliers and overseas Clinical spectrum and evolution of immune checkpoint inhibitors toxicities over a decadea worldwide perspective eClinicalMedicine